| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-5793(00)01154-6 |
| P698 | PubMed publication ID | 10675541 |
| P2093 | author name string | M Chen | |
| T Masaki | |||
| T Sawamura | |||
| H Fujiwara | |||
| T Aoyama | |||
| P2860 | cites work | Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma | Q24311702 |
| An endothelial receptor for oxidized low-density lipoprotein | Q24323462 | ||
| Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor | Q24531178 | ||
| Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions | Q28137864 | ||
| Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation | Q28143907 | ||
| Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells | Q28279585 | ||
| Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene | Q28290435 | ||
| The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin | Q28296378 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 | ||
| Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells | Q35607034 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells | Q36265106 | ||
| Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha | Q40986652 | ||
| Altered expression of alpha-actin, smooth muscle myosin heavy chain-1 and calponin in cultured smooth muscle cells by oxidized low density lipoproteins | Q41051581 | ||
| High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. | Q50521487 | ||
| Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins | Q59060592 | ||
| Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture | Q68646151 | ||
| Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis | Q71055872 | ||
| Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2 | Q71143962 | ||
| Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells | Q71561362 | ||
| Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats | Q73702881 | ||
| Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms | Q74450479 | ||
| Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells | Q77114847 | ||
| Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells | Q77827275 | ||
| Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein | Q78195714 | ||
| P433 | issue | 2-3 | |
| P304 | page(s) | 217-220 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells | |
| P478 | volume | 467 |
| Q38724228 | Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise |
| Q50351148 | C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets. |
| Q90055176 | C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity |
| Q28533974 | Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress |
| Q24532675 | Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding |
| Q46278173 | Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases |
| Q36022217 | Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin |
| Q37639902 | Endothelium and its alterations in cardiovascular diseases: life style intervention |
| Q36744066 | Expression and localization of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in murine and human placentas |
| Q50059271 | Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack |
| Q35821202 | Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested |
| Q41807188 | Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice |
| Q37690728 | LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies |
| Q37297831 | LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma |
| Q28565059 | LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt |
| Q34712581 | LOX-1 plays an important role in ischemia-induced angiogenesis of limbs |
| Q40376526 | LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells |
| Q38128283 | LOX-1, OxLDL, and atherosclerosis |
| Q34774368 | LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis |
| Q38829882 | LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis |
| Q38155327 | LOX-1: a male hormone-regulated scavenger receptor for atherosclerosis |
| Q35161109 | Lectin-like Ox-LDL receptor is expressed in human INT-407 intestinal cells: involvement in the transcytosis of pancreatic bile salt-dependent lipase |
| Q43719523 | Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) supports cell adhesion to fibronectin |
| Q40061736 | Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat |
| Q64108192 | Mass Spectrometric Imaging Reveals Temporal and Spatial Dynamics of Bioactive Lipids in Arteries Undergoing Restenosis |
| Q35323782 | Myocardin regulates vascular smooth muscle cell inflammatory activation and disease |
| Q34674199 | New scavenger receptors and their functions in atherogenesis |
| Q38852365 | Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis |
| Q51805875 | Renal injury: similarities and differences in male and female rats with the metabolic syndrome. |
| Q38299554 | Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein |
| Q39335213 | Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation. |
| Q35475499 | The discovery of LOX-1, its ligands and clinical significance |
| Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
Search more.